To determine the potential clinical relevance of our observations in IL-6 KO mice, we next examined the efficacy of doxorubicin treatment when combined with IL-6R blockade in WT animals bearing B-ALL. This evidence concerns the gene IL6 and acute lymphoblastic leukemia.